neuroClues closes €10M Series A to bring its eye-tracking Parkinson’s diagnostic to European and US neurologists

The Next Web
Read full post
NeuroClues secured €10 million in Series A funding to advance its eye-tracking technology for Parkinson's diagnosis, aiming to expand access among neurologists in Europe and the US. The funding will support clinical trials and regulatory approvals to bring this diagnostic tool to market.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News